Key result
Beta-adrenergic stimulation with isoprenaline prevented tachycardia-induced upregulation of IL6R by modulating NCX and CaMKII in rat cardiomyocytes.
Why the study?
Excessive β-adrenergic stimulation and tachycardia trigger cardiac remodeling, but their exact cellular effects and potency to modulate cardiomyocyte gene expression remain elusive.
β-adrenergic signaling demonstrates a previously unrecognized protective role in preventing IL6R overactivation during increased cardiac workload, suggesting potential nuances in the cellular effects of β-blocker therapy.
Tachycardia may drive remodeling via NCX upregulation and CaMKII in cardiomyocytes; hypothesis-generating for human studies.
Excessive β-adrenergic stimulation and tachycardia are potent triggers of cardiac remodeling; however, their exact cellular effects remain elusive. Here, we sought to determine the potency of β-adrenergic stimulation and tachycardia to modulate gene expression profiles of cardiomyocytes. Using neonatal rat ventricular cardiomyocytes, we showed that tachycardia caused a significant upregulation of sodium–calcium exchanger (NCX) and the activation of calcium/calmodulin-dependent kinase II (CaMKII) in the nuclear region. Acute isoprenaline treatment ameliorated NCX-upregulation and potentiated CaMKII activity, specifically on the sarcoplasmic reticulum and the nuclear envelope, while preincubation with the β-blocker propranolol abolished both isoprenaline-mediated effects. On a transcriptional level, screening for hypertrophy-related genes revealed tachycardia-induced upregulation of interleukin-6 receptor (IL6R). While isoprenaline prevented this effect, pharmacological intervention with propranolol or NCX inhibitor ORM-10962 demonstrated that simultaneous CaMKII activation on the subcellular Ca2+ stores and prevention of NCX upregulation are needed for keeping IL6R activation low. Finally, using hypertensive Dahl salt-sensitive rats, we showed that blunted β-adrenergic signaling is associated with NCX upregulation and enhanced IL6R signaling. We therefore propose a previously unrecognized protective role of β-adrenergic signaling, which is compromised in cardiac pathologies, in preventing IL6R overactivation under increased workload. A better understanding of these processes may contribute to refinement of therapeutic options for patients receiving β-blockers.
No takes yet. Share an insight, caveat, or question.
Matzer et al. (2022) studied Cardiac remodeling. Beta-adrenergic stimulation (isoprenaline) vs. Tachycardia alone / propranolol was evaluated on Gene expression profiles (NCX, CaMKII, IL6R). Beta-adrenergic stimulation with isoprenaline prevented tachycardia-induced upregulation of IL6R by modulating NCX and CaMKII in rat cardiomyocytes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: